account_circle info brightness_medium left_panel_close view_agenda grid_view

expand_moreexpand_less

Bosnia & Herzegovina

World

favorites

archive

We use cookies to provide some features and experiences in QOSHE

More information . Close

What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia?

What is lecanemab, the newly approved Alzheimer’s drug? Can it really slow down dementia?

The drug may slow the progression of Alzheimer’s disease, but it doesn’t improve the symptoms. It’s also incredibly expensive.

Steve Macfarlane

The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it?

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

Steve Macfarlane

Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked

A Korean study published recently suggests people with type 2 diabetes who are prescribed a particular class of drug might be at a significantly...

04.09.2024 10

Steve Macfarlane